Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Madhav Thambisetty

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
JAMA Network Open|July 11, 2020
Plasma Apolipoprotein E Levels and Risk of Dementia-You Are the Company You KeepMadhav Thambisetty
Biomarkers in Medicine|December 8, 2010
Do extracellular chaperone proteins in plasma have potential as Alzheimer's disease biomarkers?Madhav Thambisetty
American Journal of Physiology. Cell Physiology|June 16, 2017
Understanding mechanisms and seeking cures for Alzheimer's disease: why we must be "extraordinarily diverse"Madhav Thambisetty
Biomarkers in Medicine|April 14, 2010
Blood-based biomarkers of Alzheimer's disease: challenging but feasibleMadhav Thambisetty, Simon Lovestone
JAMA|May 6, 2024
Conveying Risks of Harm in Alzheimer Disease by Amyloid LoweringMadhav Thambisetty, Robert Howard
Journal of the American Geriatrics Society|April 16, 2014
Soluble interleukin-6 receptor levels and risk of dementia: one more signpost on a long road aheadMadhav Thambisetty, Luigi Ferrucci
Nature Reviews. Neurology|January 7, 2023
Lecanemab trial in AD brings hope but requires greater clarityMadhav Thambisetty, Robert Howard
JAMA Neurology|March 13, 2023
Lecanemab and APOE Genotyping in Clinical Practice-Navigating Uncharted TerrainMadhav Thambisetty, Robert Howard
Expert Review of Molecular Diagnostics|September 7, 2004
Diagnosis and management of MELASMadhav Thambisetty, Nancy J Newman
Biomarkers in Medicine|March 15, 2018
α2-macroglobulin in Alzheimer's disease: new roles for an old chaperoneSahba Seddighi, Vijay Varma, Madhav Thambisetty
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
JAMA Network Open|July 11, 2020
Plasma Apolipoprotein E Levels and Risk of Dementia-You Are the Company You KeepMadhav Thambisetty
Biomarkers in Medicine|December 8, 2010
Do extracellular chaperone proteins in plasma have potential as Alzheimer's disease biomarkers?Madhav Thambisetty
American Journal of Physiology. Cell Physiology|June 16, 2017
Understanding mechanisms and seeking cures for Alzheimer's disease: why we must be "extraordinarily diverse"Madhav Thambisetty
Biomarkers in Medicine|April 14, 2010
Blood-based biomarkers of Alzheimer's disease: challenging but feasibleMadhav Thambisetty, Simon Lovestone
JAMA|May 6, 2024
Conveying Risks of Harm in Alzheimer Disease by Amyloid LoweringMadhav Thambisetty, Robert Howard
Journal of the American Geriatrics Society|April 16, 2014
Soluble interleukin-6 receptor levels and risk of dementia: one more signpost on a long road aheadMadhav Thambisetty, Luigi Ferrucci
Nature Reviews. Neurology|January 7, 2023
Lecanemab trial in AD brings hope but requires greater clarityMadhav Thambisetty, Robert Howard
JAMA Neurology|March 13, 2023
Lecanemab and APOE Genotyping in Clinical Practice-Navigating Uncharted TerrainMadhav Thambisetty, Robert Howard
Expert Review of Molecular Diagnostics|September 7, 2004
Diagnosis and management of MELASMadhav Thambisetty, Nancy J Newman
Biomarkers in Medicine|March 15, 2018
α2-macroglobulin in Alzheimer's disease: new roles for an old chaperoneSahba Seddighi, Vijay Varma, Madhav Thambisetty
Pageof 13